| ［1］ Arvin A M.Varicellazoster Virus//David M K,Peter M H.Fields Virology.Philadelphia:LippincottRaven Publishers,2001:27312767.
［2］ Hosoda F, Nishimura S, Uchida H, et al. An F factor based cloning system for large DNA fragments. Nucleic Acids Res, Res. 1990,18(13):3863 3869.
［3］ Shizuya H, Birren B, Kim U J, et al. Cloning and stable maintenance of 300 kilobase pair fragments of human DNA in Escherichia coli using an F factor based vector. Proc Natl Acad Sci USA, 1992,89(18):8794 8797.
［4］ Ioannou P A, Amemiya C T, Garnes J,et al. A new bacteriophage P1 derived vector for the propagation of large human DNA fragments. Nat Genet, 1994,6(1):84 89.
［5］ Woo S S, Jiang J, Gill B S, Paterson A H, et al. Construction and characterization of a bacterial artificial chromosome library of Sorghum bicolor. Nucleic Acids Res,1994,22(23):4922 4931.
［6］ Hess N, Franz T, Kollek R, et al. Molecular cloning of Rauscher spleen focus forming virus and biological properties of the cloned virus. J Gen Virol,1984,65 (12):2225 2235.
［7］ Messerle M，Cmkovic I，Hanunerschmidt W，et al．Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromotome. Prec Nad Acad Sci USA，1997，94(26)：14759 14763.
［8］ Zhou F, Li Q, Gao S J. A sequence independent in vitro transposon based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes. Nucleic Acids Res, 2009,37(1):e2.
［9］ Creed R, Satyaprakash A, Ravanfar P. Varicella zoster vaccines. Dermatol Ther, 2009,22(2):143 149.
［10］ Nagaike K, Mori Y, Gomi Y, et al. Cloning of the varicella zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine,2004,22(29 30):4069 4074.
［11］ Yoshii H, Somboonthum P,Takahashi M, et al. Cloning of full length genome of varicella zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus.Vaccine,2007,25(27):5006 5012.
［12］ Zhang Z, Rowe J, Wang W, et al. Genetic analysis of varicella zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol,2007,81(17):90249033.
［13］ Cohen J I, Seidel K E. Generation of varicella zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci U S A,1993,90(15):7376 7380.
［14］ Niizuma T, Zerboni L, Sommer M H, et al. Construction of varicella zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID hu mouse model. J Virol, 2003,77(10):6062 6065.
［15］ Tischer B K, Kaufer B B, Sommer M, et al. A self excisable infectious bacterial artificial chromosome clone of varicella zoster virus allows analysis of the essential tegument protein encoded by ORF9. J Virol, 2007,81(23):13200 13208.
［16］ Tischer B K,von Einem J,Kaufer B, et al.Two step red mediated recombination for versatile high efficiency markerless DNA m anipulation in Escherichia coli. Biotechniques,2006,40(2):191 197.
［17］ Wussow F, Fickenscher H, Tischer B K. Red mediated transposition and final release of the mini F vector of a cloned infectious herpesvirus genome. PLoS One,2009,4(12):e8178.
［18］ Zhang Y, Buchholz F, Muyrers J P, et al. A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet,1998,20(2):123 128.
［19］ Yang X W, Model P, Heintz N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol,1997,15(9):859 865.
［20］ Kim S Y, Horrigan S K, Altenhofen J L, et al.Modification of bacterial artificial chromosome clones using Cre recombinase: introduction of selectable markers for expression in eukaryotic cells. Genome Res,1998,8(4):404 412.
［21］ Song M J, Hwang S, Wong W H, et al. Identification of viral genes essential for replication of murine gamma herpesvirus 68 using signature tagged mutagenesis. Proc Natl Acad Sci USA,2005,102(10):3805 3810.
［22］ Sadaoka T,Yoshii H,Imazawa T,et al. Deletion in open reading frame 49 of varicella zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J Virol,2007,81(22):12654 12665.
［23］ Chaudhuri V, Sommer M, Rajamani J, et al. Functions of Varicella zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol, 2008,82(20):10231 10246.
［24］ Yamagishi Y, Sadaoka T, Yoshii H, et al.Varicella zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell to cell spread. J Virol,2008,82(2):795 804.
［25］ Zhang Z, Huang Y, Zhu H. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods,2008,148(1 2):197 204.
［26］ Yoshii H, Sadaoka K, Matsuura M,et al. Varicella zoster virus ORF 58 gene is dispensable for viral replication in cell culture.Virol J,2008,30;5:54.
［27］ Lowe R S, Keller P M, Keech B J, et al. Varicella zoster virus as a live vector for the expression of foreign genes. Proc Natl Acad Sci USA,1987,84(11):3896 3900.
［28］ Shiraki K, HayakawaY, Mori H, et al. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen. J Gen Virol,1991,72(Pt 6):1393 1399.
［29］ Shiraki K, Sato H, Yoshida Y, et al. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen. J Med Virol,2001,64(2):89 95.
［30］ Heineman T C, Connelly B L, Bourne N, et al. Immunization with recombinant varicella zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol,1995,69(12):8109 8113.
［31］ Heineman T C, Pesnicak L, Ali M A, et al. Varicella zoster virus expressing HSV 2 glycoproteins B and D induces protection against HSV 2 challenge. Vaccine,2004,22(20):2558 2565.
［32］ Somboonthum P, Yoshii H, Okamoto S, et al. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin neuraminidase protein as a polyvalent live vaccine. Vaccine,2007,17,25(52):8741 8755. |
